Posted by Michael Wonder on 17 Sep 2020
11 state treasurers call on Gilead to reduce remdesivir pricing
18 September 2020 - The medicine has shown promise as a treatment for novel coronavirus.
As the U.S. approaches 200,000 coronavirus deaths, a coalition of 11 state treasurers is calling on drug maker Gilead Sciences to reduce the price of remdesivir, its promising treatment for some patients of COVID-19.
In a letter to the California-based drug maker on Wednesday, the state treasurers, led by Pennsylvania's Joe Torsella and Ohio's Robert Sprague, asked the company to "responsibly commit to being a part of our nation's recovery from COVID-19, both medically and economically, by repricing this drug more affordably."
